What's new

Human medicines European public assessment report (EPAR): Polivy, polatuzumab vedotin, Date of authorisation: 16/01/2020, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Polivy, polatuzumab vedotin, Date of authorisation: 16/01/2020, Revision: 6, Status: Authorised

Mar 21, 2025 - 15:34
 0
Human medicines European public assessment report (EPAR): Polivy, polatuzumab vedotin, Date of authorisation: 16/01/2020, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Polivy, polatuzumab vedotin, Date of authorisation: 16/01/2020, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

UPDATE: Director of NIH's National Human Genome Research Institute departs

Next Article

Announcement of opinions for Friday, March 21 (complete)

Related Posts

Orphan designation: Tafasitamab Treatment of follicular lymphoma, 26/02/2025 Positive

Orphan designation: Tafasitamab Treatment of follicular...

Mar 11, 2025  0

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 March 2025

Meeting highlights from the Committee for Veterinary Me...

Mar 14, 2025  0

EMEA-003507-PIP01-23

EMEA-003507-PIP01-23

Feb 13, 2025  0